Log In
BCIQ
Print this Print this
 

Razadyne, galantamine (formerly Reminyl)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAcetylcholinesterase (AChE) inhibitor and nicotinic receptor modulator
Molecular Target Acetylcholinesterase (AChE) ; Nicotinic receptor
Mechanism of ActionAcetylcholinesterase (AChE) inhibitor; Nicotinic receptor modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD); Treat Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI); Treat dementia in cerebrovascular disease patients; Treat mild to moderate Alzheimer's disease (AD)
Regulatory Designation
PartnerJohnson & Johnson;
Takeda Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today